The Latest Oncology Treatment & Support News
Blocking DNA repair enzyme could help treat certain cancers
Researchers at the Francis Crick Institute, London, UK, have found a new way to prevent…
Browsing: Treatment & Support
SU2C research leads to FDA approval of new first-line treatment for colorectal cancer
The FDA recently approved the immunotherapy drug pembrolizumab as a first-line treatment for patients with…
Study identifies distinct sub-types of aggressive tumours to allow for targeted treatment
A new study led by clinician-scientists from the National Cancer Centre Singapore (NCCS), with collaborators…
Novel principle for cancer treatment shows promising effect
Researchers at Karolinska Institutet in Sweden report in the journal Nature that they have developed novel first-in-class…
Gene could help predict response to cervical cancer treatment
UCLA researchers have identified a potential diagnostic marker that could help predict how likely someone…
SABCS 2020: CTC dynamics may predict treatment response/prognosis in metastatic breast cancer patients
Early circulating tumour cell dynamics were associated with overall survival in patients with metastatic breast…
Study of ‘exceptional responders’ yields clues to cancer and potential treatments
In a comprehensive analysis of patients with cancer who had exceptional responses to therapy, researchers…
Early treatment with lorlatinib improves survival in some lung cancer patients
Lung cancer patients with a specific genetic alteration lived longer and were protected against metastasis…
A new diagnostic method predicts which cancer patients will respond to immunotherapy
Immunotherapy is a cancer treatment that helps the patient’s immunological system to combat it and…
Singapore scientists identify potential new biomarker to better personalise cancer therapy
Researchers from Duke-NUS Medical School, Erasmus University Medical Center, Yale-NUS College and Duke University, USA,…